Is there any dominant culture in global aeronautical settings?

This article investigates the existence of dominant culture in global aeronautical settings. The author presents the nature of aeronautical communication and classifies its users into two main groups: native and non-native speakers of English. Traditionally, presented high-risk aviation environment is devoid of any cultural models to follow. However, the author demonstrates how a human factor may modify prescribed rules and points to the real-life examples of dominant culture observed in aeronautical communication. The article hopes to contribute to intercultural aeronautical communication as well as multiculturalism

Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.

Survivin is an inhibitor of apoptosis that plays a significant role in cell cycle regulation and is important for survival prognosis in many neoplasms. Survivin expression was assessed by in situ hybridization (ISH) in 60 consecutive patients (54 males and 4 females) with NSCLC treated between 1993 and 1997. The examined patients had IIB and IIIA stage according to TNM system. In all cases the chemotherapy with cisplatin and etoposide (2 cycles) was administered prior the surgery; in patients responding to the therapy one more cycle was applied. Survivin gene overexpression was observed in 35 patients (58.3%). There was no correlation between survivin mRNA level and histological type of tumor, stage of cell differentiation, stage of disease according to TNM classification, performance status according to WHO and number of chemotherapy regimens administered (p > 0.05). However, the correlation between survivin gene expression and response to the chemotherapy was statistically significant (p = 0.04). Statistical analysis showed that median survival in patients with survivin gene overexpression was shorter (14.0 months) as compared to patients with no expression (60.0 months; p = 0.00002). In survival assessment by means of Kaplan-Meier test, 14.3% of five-year survival was achieved in the former group versus 60% in the latter (p = 0.00003). Univariate analysis (log-rank test) showed that significant independent prognostic factors in NSCLC included: stage of the disease according to TNM classification (p = 0.006), response to chemotherapy (p = 0.005) and pattern of survivin gene expression (p = 0.00003). Multivariate analysis utilizing Cox's model showed that for survival assessment the stage according to TNM, response to the chemotherapy and survivin expression estimated by means of ISH are of statistical significance (p=0.00001). The calculated predictive values showed that ISH technique was quite accurate in assessment of five-year survival. Our data show that survivin expression may be used as a prognostic factor and a target for therapy

148. Changes in lateral dimensions of irradiated volume and their impact on the accuracy of dose delivery during radiotherapy for head and neck cancer

AimTo assess changes in lateral dimensions of irradiated volume during head and neck cancer radiotherapy and their impact on dose delivery accuracy.Material and methodsLateral dimensions of irradiated volumes were measured in 5 predefined points using computed tomography, simulator and manually with calipers, prior to treatment and then bi-weekly. For each measurement reference point dose was calculated and verified using in vivo dosimetry. Early radiation reactions, patient's weight changes and the need to modify radiotherapy accessories were also assessed. All these parameters were analyzed in relation to tumor site and stage, treatment field size, radiation dose and the degree of radiation reactions.ResultsThe study included 33 head and neck cancer patients (24 men and 9 women) aged 24–77 (median 56). All patients were irradiated using the parallel opposed megavoltage fields ranging from 49 to 180 cm2 (median 121 cm2) to the dose of 44 to 80 Gy (median 66 Gy). Radiation reactions included mucositis (grade 3 – 1 patient, grade 2 – 17 patients, grade 1 – 13 patients) and dysphagia (grade 2 – 12 patients, grade 1 – 16 patients). The body mass changes during radiotherapy ranged from −18 to +4 kg (median −5 kg). In 1 patient radiotherapy accessories had to be modified three times during the treatment, in 6 – twice and in 10 – once. Lateral dimensions changes >5 mm occurred in all but one patient (range −37 to +16 mm). Theoretical doses calculated for changed dimensions varied from prescribed by −2.5% to +6% (median +2%). Differences larger than 5% were present in 4.8% of calculations. In vivo dose measurements (after introduction of necessary corrections) demonstrated difference from prescribed dose larger than 5% in 7.6% of measurements.ConclusionChanges in the lateral dimensions of irradiated volume during head and neck cancer radiotherapy may lead to some inaccuracies in delivered doses. Such situations may necessitate adequate corrections of dose calculations and modification of radiotherapy accessories during the course of treatment

Local structure and conductivity behaviour in Bi7WO13.5

Total neutron scattering analysis reveals details of cation coordination and vacancy distribution in Bi7WO13.5.</p

242. Analiza ekspresji EGFR i angiogenezv w utkaniu niedrobnokomórkowego raka płuc oraz związku z czasem przeżycia pacjentów w stadiach zaawansowania klinicznego I-IIIA

Cel pracyWciąż niezadowalające wskaźniki przeżycia pacjentów z rakiem płuca, mimo radykalnego leczenia operacyjnego, skłaniają do poszukiwań nowych czynników prognostycznych. Wiadomym jest, że receptor naskórkowego czynnika wzrostu (EGFR) wpływa na wzrost komórek guza i jego progresję, jak również tworzenie przerzutów – głównie poprzez oddziaływanie na tworzenie nowych naczyń krwionośnych. Jego prognostyczna rola u pacjentów z niedrobnokomórkowym rakiem płuca (NRP) jest niejasna. Natomiast gęstość naczyń krwionośnych (GNK), będąca miernikiem angiogenezy w guzie, jest podawana jako marker prognostyczny w wielu nowotworach. Celem naszego badania była ocena zależności między ekspresją EGFR i GNK w utkaniu guza nowotworowego a przeżyciem pacjentów z NRP.Materiał i metodyBadaniem objęto 75 pacjentów z NRP w stadiach zaawansowania klinicznego I-IIIA. Wycinki z guza pobierano z materiału operacyjnego, utrwalonego w formalinie. Na uzyskanych skrawkach parafinowych wykonywano odczyny immunohistochemiczne z zastosowaniem monoklonalnego przeciwciała przeciw receptorowi naskórkowego czynnika wzrostu oraz monoklonalnego przeciwciała przeciw CD31.WynikiWśród 75 pacjentów było 5 kobiet (6.7%) i 70 mężczyzn (93.3%) w wieku od 42 lat do 74 lat (średnio 59 lat). W badanej grupie chorych stwierdzono raka płaskonabłonkowego u 53 pacjentów (70.7%), gruczolakoraka u 11 chorych (14.7%) i raka wielkokomórkowego także u 11 pacjentów. Analizując uzyskane dane nie stwierdzono istotności statystycznej między ekspresją EGFR i czasem przeżycia pacjentów. Również GNK nie miała istotnego wpływu na przeżycie pacjentów. Jedynie stan węzłów chłonnych (cecha N; p<0.05), typ histologiczny raka (p<0.001) oraz wiek (p<0.05) w badanej grupie chorych miały istotny statystycznie wpływ na czas przeżycia.WnioskiUzyskane w tym badaniu wyniki nie są zgodne z wynikami innych doniesień mówiących o tym, że ekspresja EGFR i GNK w NRP mogą być traktowane jako czynniki prognostyczne. Należy jednak podkreślić, że analizowana grupa pacjentów była mała, a większość chorych (59 pacjentów, 78.7%) znajdowała się w stadium znacznego zaawansowania nowotworu